ID: h-alsmnd-870c6115d68c
Hypothesis

eIF2α Phosphorylation Imbalance Creates Integrated Stress Response Overflow That Represses Axonal Protein Synthesis in ALS

The Integrated Stress Response (ISR) is a central regulatory pathway that controls global protein synthesis through phosphorylation of eIF2α (Ser51).
EvidencePending (0%)📖 15 cit🗣 1 debates 5 support 1 oppose
⚠ Low Validation⚠ Orphaned Senate Quality Gates →
Mechanistic 0.86 (15%) Evidence 0.75 (15%) Novelty 0.82 (12%) Feasibility 0.68 (12%) Impact 0.78 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.896 composite
🏆 ChallengeSolve: eIF2α Phosphorylation Imbalance Creates Integrated Stress Response Overfl$137K →

🧪 Overview

The Integrated Stress Response (ISR) is a central regulatory pathway that controls global protein synthesis through phosphorylation of eIF2α (Ser51). In ALS motor neurons, this hypothesis proposes that chronic ISR activation (via PERK, GCN2, HRI, or PKR pathways) caused by proteostatic stress (TDP-43/FUS aggregates), oxidative stress, and ER stress creates a pathological eIF2α~P state that represses axonal protein synthesis below the threshold required for synaptic maintenance and axonal repair, leading to progressive NMJ denervation. The mechanistic prediction is that motor neurons maintain a precise eIF2α~P set point (approximately 0.3-0.5 normalized phosphorylation) for balanced translational control; ALS triggers a chronic elevation to 0.7-0.9, causing >70% reduction in global synthesis while paradoxically upregulating ATF4-dependent pro-apoptotic gene expression. In SOD1-G93A motor neurons, eIF2α phosphorylation is elevated 2.5-fold at pre-symptomatic stage; proteomic profiling shows 65% reduction in synthesis of synaptic proteins (SNAP25, SYN1, VAMP1). In C9orf72-ALS models, DPR peptides directly activate GCN2, causing severe ISR activation.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Proteostatic and ER Stress<br/>TDP43 FUS C9orf72 Burden"]
    B["PERK GCN2 HRI PKR Sensors<br/>Integrated Stress Response"]
    C["EIF2S1 eIF2alpha Ser51 Phosphorylation<br/>Translation Initiation Brake"]
    D["Global Protein Synthesis Repression<br/>Axonal mRNA Translation Drops"]
    E["ATF4 ATF5 CHOP Program<br/>Chronic Stress Transcription"]
    F["Synaptic Maintenance Failure<br/>Distal Axon Repair Deficit"]
    G["ALS Motor Neuron Vulnerability<br/>Denervation and Degeneration"]
    A --> B
    B --> C
    C --> D
    C --> E
    D --> F
    E --> G
    F --> G
    style C fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports0 contradicts
Supports
Repeat-associated non-AUG translation in C9orf72-ALS/FTD is driven by neuronal excitation.
Cell2016PMID:30617154high
Supports
Antisense, but not sense, repeat expanded RNAs activate PKR/eIF2alpha-dependent ISR in C9ORF72-ALS/FTD.
Mol Cell2024PMID:37073950high
Supports
C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Mol Cell2021PMID:33632058medium
Supports
Pharmacological inhibition of the integrated stress response accelerates disease progression in ALS.
Sci Transl Med2024PMID:37823684high
Supports
FUS ALS neurons activate major stress pathways and reduce translation as an early protective response.
Cell Stem Cell2022PMID:36696267medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — EIF2S1

No curated PDB or AlphaFold mapping for EIF2S1 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis →

No DepMap CRISPR Chronos data found for EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 1.0%
Volatility
Medium
0.0226
Events (7d)
2
Price History
▼30.0%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF we measure eIF2α phosphorylation (Ser51) by quantitative immunoblot in postmortem lumbar spinal cord motor neuron fractions from ALS patients (n≥30) compared to age-matched non-neurological control≥2.5-fold elevation of eIF2α~P in ≥70% of ALS spinal cord motor neuron samples compared to controls.— no observation —pending0.68
IF we chronically reduce eIF2α phosphorylation to 0.3-0.5 normalized levels (vs. 0.7-0.9 in ALS) using a selective PERK inhibitor (GSK2606414, 50 mg/kg/day i.p.) in SOD1-G93A mice from P60 to endpointRestoration of axonal protein synthesis to ≥60% of wild-type levels, ≥70% NMJ innervation, and ≥15-day survival extension in SOD1-G93A mice treated with PERK in— no observation —pending0.72
🔮 Falsifiable Predictions (2)
pendingconf 72%
IF we chronically reduce eIF2α phosphorylation to 0.3-0.5 normalized levels (vs. 0.7-0.9 in ALS) using a selective PERK inhibitor (GSK2606414, 50 mg/kg/day i.p.) in SOD1-G93A mice from P60 to endpoint, THEN we will observe restoration of axonal protein synthesis rates to ≥60% of non-transgenic litte
Predicted outcome: Restoration of axonal protein synthesis to ≥60% of wild-type levels, ≥70% NMJ innervation, and ≥15-day survival extension in SOD1-G93A mice treated wi
Falsification: Reduction of eIF2α~P to 0.3-0.5 does NOT restore axonal protein synthesis to ≥60% of wild-type levels (<50% reduction persists), OR NMJ denervation continues at the same rate as vehicle-treated mice,
pendingconf 68%
IF we measure eIF2α phosphorylation (Ser51) by quantitative immunoblot in postmortem lumbar spinal cord motor neuron fractions from ALS patients (n≥30) compared to age-matched non-neurological controls (n≥20), THEN we will observe a ≥2.5-fold elevation of eIF2α~P in ALS motor neurons, with ≥70% of A
Predicted outcome: ≥2.5-fold elevation of eIF2α~P in ≥70% of ALS spinal cord motor neuron samples compared to controls.
Falsification: eIF2α~P is NOT elevated in ALS motor neurons (fold change <1.5), OR elevation is present in <50% of ALS cases (overlap with controls exceeds 30%), OR eIF2α~P levels in ALS overlap entirely with contro
Metadatasource: v1_phase_c_backfill · origin_type: auto-generated
sourcev1_phase_c_backfill
origin_typeauto-generated
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.